FIELD: pharmacology.
SUBSTANCE: invention relates to pharmaceutical composition, which contains sodium alginate, 5-fluoruracil, additionally contains nanoemulsion of amphiphilic polymer N-vinylpyrrolidone with its ratio with sodium alginate 1:2 weight parts, where content of sodium alginate constitutes 2-3 wt %, and contains 5-fluoruracil in quantity 0.5-5.0 wt %, the remaining part - water. Claimed pharmaceutical composition does not lose rheological properties at sterilisation and can be more widely applied in treatment of different oncologic diseases, which require higher viscosity of introduced composition. Application of composition with increased viscosity makes it possible to increase term of prolongation of action of introduced in it medication basing on required medical indications.
EFFECT: reduction of treatment toxicity, increase of shock dose of medication and achievement of prolongation of its action, preservation of composition viscosity after sterilisation.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION FOR PREPARING DOSAGE FORM HAVING PROLONGED ACTION | 2012 |
|
RU2519723C1 |
| METHOD OF OBTAINING THERAPEUTIC HYDROGEL | 2014 |
|
RU2563232C1 |
| METHOD OF OBTAINING MEDICINAL COMPOSITION FOR ITS APPLICATION ON TEXTILE MATERIAL | 2009 |
|
RU2400250C1 |
| METHOD FOR PRODUCING THERAPEUTIC TISSUE | 2014 |
|
RU2539381C1 |
| WOUND TISSUE | 2012 |
|
RU2483755C1 |
| HEALING MATERIAL AND METHOD FOR BTAINING THEREOF | 2016 |
|
RU2627609C1 |
| METHOD FOR PRODUCING A THERAPEUTIC HYDROGEL | 2017 |
|
RU2653411C1 |
| METHOD OF COMPOSITION CREATION FOR MEDICAL PREPARATION DELIVERY IN ORGANISM CAVITY AT DISEASES | 2007 |
|
RU2352359C1 |
| COMPOSITION FOR PREPARATION OF MEDICINAL FORM POSSESSING PROLONGED ACTION FOR TREATMENT OF OROPHARYNGEAL ZONE | 2010 |
|
RU2432942C1 |
| PARENTERAL PREPARATION AND METHOD FOR MAKING THEREOF | 2008 |
|
RU2367472C1 |
